As the Trump administration begins to make its mark on the Medicare drug price negotiation program, litigation over the ...

A new fight is brewing over the Medicare drug price negotiation program after the Trump administration proposed to consider ...

The sweeping One Big Beautiful Bill Act, signed into federal law July 4, amended CMS’ drug price negotiations authority that could absolve nearly $5 billion in projected savings, according to ...

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Biden-era drug price negotiations that doubles down on actions they’ve resisted since ...

The Biden administration on Wednesday released a blueprint for implementing the Medicare drug price negotiation process set in motion by last year’s Inflation Reduction Act. The process will get ...

In advance of CMS’ negotiated price for the blood thinner taking effect next year, partners Bristol Myers Squibb and Pfizer ...

CMS is brokering outcomes-based agreements on behalf of Medicaid programs. Thirty-three states, along with Washington, D.C., ...

Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic.

UnitedHealth Group is currently undervalued due to an overblown market reaction to profitability challenges. Click here to ...

Medicare inflation rebates fail to curb rising drug prices, highlighting the need for further policy action to control costs.

The Inflation Reduction Act (IRA) made changes to the way drugs are covered and reimbursed in Medicare. It has been ...

Learn about the benefits that become permanent features of Medicare in 2026 and how they have been changed or updated since ...